Market Size & Trends
The global gynecological examination chairs market size was estimated at USD 338.0 million in 2022 and is expected to grow at a compound annual growth rate (CAGR) of 6.1% from 2023 to 2030. The growth of the market is attributed to the increasing prevalence of gynecological disorders and rising government support in the form of favorable funding and reimbursement policies. Moreover, rising awareness regarding the benefits associated with the adoption of gynecological diagnosis and treatment, coupled with increasing investment by key players in the R&D of technologically advanced medical devices, is driving the demand for the market.
The rising incidences of gynecological disorders such as cervical dysplasia, pelvic pain, uterine fibroids, menstrual disorders, and gynecological cancers are fueling the demand for advanced and cost-effective gynecological examination chairs. According to WHO, in 2020, cervical cancer was the fourth most common cancer in women across the globe. It was the main cause of 342,000 deaths, and around 604,000 new cases of cervical cancer cases were registered worldwide. Moreover, 90% of the deaths and new cases caused by cervical cancer occurred in middle and low-income economies. This has created an opportunity for market growth in developing nations over the forecast period.
The rising investments by prominent players in the research and development of gynecological examination chairs are driving market growth. Market players are introducing advanced attachments to their gynecological examination chairs, such as leg support, to be capable of providing enhanced patient comfort. For instance, in July 2021, SCHMITZ introduced UniLeg leg support that is adjustable and well-padded to offer flexibility and comfortable leg positioning.
The presence of favorable government policies is contributing to the rising adoption of gynecological examination chairs in healthcare facilities. For instance, in March 2023, as a part of the Women’s Health Strategy, the government of the UK announced an investment of USD 27.1 million for the development of women’s health hubs. These health hubs are expected to provide quality care and improved access to services for contraception, menstrual problems, menopause care, pelvic pain, and more. Similarly, in December 2022, the United States Congress allocated USD 7.6 billion to the National Cancer Institute. The rising government support in the form of funding is anticipated to drive the market over the forecast period.
Type Insights
Based on type, the market is segmented into electric and non-electric. The electric segment witnessed the largest market share of 51.9% in 2022 and is anticipated to show the fastest growth at a CAGR of 6.6% over the forecast period. The segment growth is attributed to the availability of advanced features such as memory control, position and height adjustment, and various other electromotor settings.
Moreover, technological advancements in electric gynecological examination chairs are expected to drive the demand for the market over the forecast period. Major players are developing technologically advanced solutions that enhance the capabilities of physicians in gynecological diagnosis. For instance, in May 2020, SCHMITZ introduced an upgraded version of its video colposcope portfolio, the vidan 2. The vidan 2 is equipped with Full HD and enhanced optical zoom to detect minute details on the large touchscreen monitor.
Application Insights
Based on the application, the market is segmented into gynecological cancer, menstrual disorders, hysterectomy, pregnancy complications, and others. The gynecological cancer segment dominated the market with a share of 25.7% in 2022. The segment growth is attributed to the increasing incidences of gynecological cancer and the rising adoption of gynecological diagnosis and treatment. According to the American Cancer Society, cervical cancer is anticipated to become a major cause of around 13,900 new cases and more than 4,300 deaths in 2023. This is expected to increase the demand for technologically advanced gynecological examination chairs over the forecast period.
The menstrual disorder segment is anticipated to show the fastest growth at a CAGR of 6.4% over the forecast period, owing to the increasing prevalence of menstrual conditions such as dysmenorrhea, menorrhagia, metrorrhagia, amenorrhea, oligomenorrhea, and hypomenorrhea. According to a study published by NCBI in 2022, around 46%, 19%, and 15% of the Chinese female population suffered from dysmenorrhea, polycystic ovary syndrome, and uterine fibroids, respectively.
End Use Insights
Based on end use, the market for gynecological examination chairs is segmented into hospitals, outpatient facilities, and others. The hospitals segment dominated the market with a market share of 45.7% in 2022. The growth of the segment is attributed to the increasing prevalence of gynecological disorders such as cancer, fibroids, and endometriosis has contributed to the rising hospital visits. Moreover, increasing government support in the form of funding and policies to develop healthcare infrastructures in developed and developing countries is anticipated to drive the market over the forecast period.
The outpatient facilities segment is anticipated to show the fastest growth at a CAGR of 6.9% from 2023 to 2030, owing to enhanced patient convenience, improved physician productivity, and reduced out-of-pocket costs for patients. Moreover, the presence of a favorable reimbursement scenario for patients is contributing to the rising adoption of ambulatory centers for the diagnosis and treatment of gynecological disorders, which is creating demand for advanced gynecological examination chairs. This rising demand is anticipated to create an opportunity for market growth in this segment during the forecast period.
Regional Insights
The North American region accounted for the largest market share of 31.2% in 2022. The factor contributing to the segment growth is the presence of a well-established healthcare infrastructure, raising awareness among the female population, and the prevalence of gynecological disorders in the region. According to the Office on Women’s Health, endometriosis affects around 11% of the female population with ages ranging between 15 and 44 years in America. Similarly, according to a study published by NCBI, menstrual disorders such as dysmenorrhea have a 90% prevalence in the U.S. female population. Moreover, the regional government is motivating manufacturers to develop technologically advanced gynecological examination chairs by providing favorable regulatory and reimbursement policies.
The Asia Pacific region is expected to witness the fastest growth at a CAGR of 6.4% over the forecast period owing to the high population and rising awareness regarding the benefits associated with the adoption of gynecological procedures. Moreover, the availability of trained professionals and the presence of developing healthcare facilities are driving the market growth. Global players in the market are strengthening their market position by catering to the rising demand in the region through partnerships. For instance, in August 2020, medifa, along with its partner Jindal Enterprise installed 14 medifa 6000 series mobile operating tables at the All India Institute of Medical Science in Bhubaneshwar, India.
Key Companies & Market Share Insights
The gynecological examination chairs market is consolidated, and major market players are adopting various strategies such as acquisitions, partnerships, collaborations, expansions, and new product launches to strengthen their presence in the global market. For instance, in August 2020, Zhangjiagang Medi Medical Equipment Co., ltd. received an order for 100 gynecological examination chairs from a customer located in The Dominican Republic. Moreover, in January 2020, medifa, in association with Operieren in Afrika, supported healthcare in Burkina Faso, Africa, by providing various surgical accessories and a medifa 5000 mobile operating table. Some of the prominent players in the gynecological examination chairs market include:
medifa
Zhangjiagang Medi Medical Equipment Co., Ltd.
Novak M.
SCHMITZ
Ocura
Tronwind Industries Co. Limited.
AGA SANITÄTSARTIKEL GMBH
Malvestio Spa
Favero Health Projects Spa